PMID: 12786630Jun 6, 2003Paper

Mycophenolate mofetil in refractory inflammatory bowel disease

Alimentary Pharmacology & Therapeutics
A C FordA T R Axon

Abstract

Mycophenolate mofetil has been claimed to be effective and well tolerated in refractory inflammatory bowel disease although there is little information regarding its use in clinical practice. To review our experience in achieving and maintaining remission in refractory inflammatory bowel disease and to document tolerability, major toxicity and efficacy. A retrospective audit was performed of the records of all patients with inflammatory bowel disease treated with mycophenolate mofetil (1-2 g/day) over a 3-year period. Thirty-nine patients were identified. Almost all had been intolerant of, or had not responded to azathioprine, and 38 were steroid-dependent. mycophenolate mofetil was discontinued in 22 patients, 11 due to intolerance and 10 because of lack of efficacy. Of the 17 on treatment at the end of the study period 16 were in remission and off all steroid therapy, but one needed infliximab to maintain remission. No major toxicity was noted and there was no major sepsis. Approximately 40% of patients with severe refractory inflammatory bowel disease achieved remission and complete steroid withdrawal on mycophenolate mofetil therapy, almost 30% could not tolerate the drug, and a further 30% did not respond. Mycophenolate mo...Continue Reading

References

Dec 1, 1987·Journal of the American Academy of Dermatology·W W EpinetteM C Greist
Jan 1, 1994·Comprehensive Therapy·L G Darlington, N W Ramsey
Dec 22, 1998·The American Journal of Gastroenterology·P FickertW Petritsch
Jan 29, 2000·Alimentary Pharmacology & Therapeutics·K FellermannE F Stange
Jun 3, 2000·Gut·A D JenkinsonS S Kadirkamanathan
Jun 3, 2000·Gut·J C Atherton
Aug 5, 2000·The American Journal of Gastroenterology·M LémannJ F Colombel
Oct 7, 2000·Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie·B E Sands
Feb 21, 2002·Inflammatory Bowel Diseases·Maeve M SkellyChristopher J Hawkey
Apr 4, 2002·Alimentary Pharmacology & Therapeutics·A G FraserD P Jewell
Jun 6, 2002·Lancet·Stephen B HanauerUNKNOWN ACCENT I Study Group

❮ Previous
Next ❯

Citations

Oct 11, 2007·Inflammatory Bowel Diseases·S PalaniappanP J Hamlin
Aug 12, 2006·Current Treatment Options in Gastroenterology·Sunana Sohi, Russell D Cohen
Apr 6, 2004·Current Opinion in Pharmacology·Imad Uthman
Feb 11, 2005·Current Opinion in Gastroenterology·Helen M PappaRichard J Grand
Feb 11, 2005·Current Opinion in Gastroenterology·Remo Panaccione, William J Sandborn
Jun 1, 2004·Inflammatory Bowel Diseases·Severine Vermeire, Paul Rutgeerts
Oct 14, 2009·Journal of Gastroenterology and Hepatology·Michael C Grimm
Oct 14, 2006·Paediatric Drugs·Paul A Rufo, Athos Bousvaros
Jan 18, 2008·World Journal of Gastroenterology : WJG·Patricia L Kozuch, Stephen B Hanauer
Apr 3, 2009·World Journal of Gastroenterology : WJG·Terrence Tan, Ian Craig Lawrance
Mar 1, 2006·Expert Opinion on Investigational Drugs·Felix Braun, Matthias Behrend
Jan 20, 2009·Journal of the American Academy of Dermatology·Alissa K OrvisShannon W Watkins
Jan 12, 2005·Acta Clinica Belgica·F BaertP Rutgeerts
Dec 9, 2010·Alimentary Pharmacology & Therapeutics·S C NgJ J Y Sung
Dec 4, 2003·Expert Opinion on Pharmacotherapy·Titte R SrinivasHerwig Ulf Meier-Kriesche
Aug 12, 2014·World Journal of Gastroenterology : WJG·Sara RennaAmbrogio Orlando

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.